Page last updated: 2024-08-24

carbogen and Carcinoma, Transitional Cell

carbogen has been researched along with Carcinoma, Transitional Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bentzen, SM; Hoskin, PJ; Motohashi, KJ; Rojas, AM; Saunders, MI1
Hoskin, PJ; Phillips, H; Rojas, AM; Saunders, MI1
Griffiths, JR; Howe, FA; Lofts, F; McIntyre, DJ; McSheehy, PM; Nicholson, G; Noordhuis, P; Peters, GJ; Price, NM; Rodrigues, LM; Smid, K; Stubbs, M; Wadsworth, P1

Trials

2 trial(s) available for carbogen and Carcinoma, Transitional Cell

ArticleYear
Carbogen and nicotinamide in locally advanced bladder cancer: early results of a phase-III randomized trial.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2009, Volume: 91, Issue:1

    Topics: Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma, Transitional Cell; Dose Fractionation, Radiation; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Radiotherapy Dosage; Treatment Outcome; Urinary Bladder Neoplasms

2009
Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide.
    Cancer, 2005, Jun-01, Volume: 103, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Hypoxia; Combined Modality Therapy; Disease-Free Survival; Humans; Middle Aged; Niacinamide; Oxygen; Radiotherapy, High-Energy; Survival Rate; Urinary Bladder Neoplasms

2005

Other Studies

1 other study(ies) available for carbogen and Carcinoma, Transitional Cell

ArticleYear
Issues of normal tissue toxicity in patient and animal studies--effect of carbogen breathing in rats after 5-fluorouracil treatment.
    Acta oncologica (Stockholm, Sweden), 2001, Volume: 40, Issue:5

    Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Biological Availability; Bone Marrow; Carbon Dioxide; Carcinoma, Transitional Cell; Colonic Neoplasms; Colorectal Neoplasms; Combined Modality Therapy; Fatal Outcome; Female; Fluorine Radioisotopes; Fluorodeoxyuridylate; Fluorouracil; Humans; Intestine, Small; Leucovorin; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Multiple Primary; Oxygen; Rats; Rats, Inbred WF; Sigmoid Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Urinary Bladder Neoplasms

2001